Literature DB >> 28345428

Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.

Megan L Cramer1, Guohong Shao2,3, Louise R Rodino-Klapac2,3, Louis G Chicoine2,3, Paul T Martin2,3.   

Abstract

Use of adeno-associated virus (AAV) to transduce genes into skeletal muscles can be associated with T-cell responses to viral capsid and/or to transgenic protein. Intramuscular mononuclear cell infiltrates primarily consisting of CD8+ T cells and also containing FOXP3+ regulatory T cells were present in rhesus macaque skeletal muscle treated with rAAVrh74.MCK.GALGT2 by vascular delivery. Administration of oral prednisone prior to AAV gene delivery and throughout the study reduced such infiltrates by 60% at 24 weeks post AAV delivery compared with AAV-treated animals not receiving prednisone, regardless of the presence of pre-existing AAV serum antibodies at the time of treatment. The majority of CD8+ T cells in AAV-treated muscles expressed activated caspase 3 and programmed cell death protein 1 (PD1), suggesting ongoing programmed cell death. AAV-transduced skeletal muscles also had elevated expression of programmed death ligand 2 (PDL2) on skeletal myofibers, and this increase in expression extended to muscles where transgene was not overexpressed. These data demonstrate that prednisone can reduce the extent of intramuscular T-cell infiltrates in AAV-treated muscles, which may aid in achieving long-term transgene expression, as may the induction of PDL2 expression on skeletal myofibers to promote PD1-mediated programmed T-cell death.

Entities:  

Keywords:  AAV; PD1; gene therapy; lymphocyte; muscular dystrophy; neuromuscular junction

Mesh:

Substances:

Year:  2017        PMID: 28345428      PMCID: PMC5488353          DOI: 10.1089/hum.2016.113

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  80 in total

1.  Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

Authors:  Masayoshi Ishida; Yoshiko Iwai; Yoshimasa Tanaka; Taku Okazaki; Gordon J Freeman; Nagahiro Minato; Tasuku Honjo
Journal:  Immunol Lett       Date:  2002-10-21       Impact factor: 3.685

2.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction.

Authors:  P T Martin; L J Scott; B E Porter; J R Sanes
Journal:  Mol Cell Neurosci       Date:  1999-02       Impact factor: 4.314

4.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

Review 5.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

6.  Induction of tolerance to factor VIII by transient co-administration with rapamycin.

Authors:  B Moghimi; B K Sack; S Nayak; D M Markusic; C S Mah; R W Herzog
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

7.  Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.

Authors:  Holly H Nguyen; Vianney Jayasinha; Bing Xia; Kwame Hoyte; Paul T Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

Authors:  David S Waddell; Leslie M Baehr; Jens van den Brandt; Steven A Johnsen; Holger M Reichardt; J David Furlow; Sue C Bodine
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

9.  Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B.

Authors:  Sushrusha Nayak; Debalina Sarkar; George Q Perrin; Babak Moghimi; Brad E Hoffman; Shangzhen Zhou; Barry J Byrne; Roland W Herzog
Journal:  Front Microbiol       Date:  2011-12-07       Impact factor: 5.640

10.  Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.

Authors:  Christian Mueller; Jeffrey D Chulay; Bruce C Trapnell; Margaret Humphries; Brenna Carey; Robert A Sandhaus; Noel G McElvaney; Louis Messina; Qiushi Tang; Farshid N Rouhani; Martha Campbell-Thompson; Ann Dongtao Fu; Anthony Yachnis; David R Knop; Guo-Jie Ye; Mark Brantly; Roberto Calcedo; Suryanarayan Somanathan; Lee P Richman; Robert H Vonderheide; Maigan A Hulme; Todd M Brusko; James M Wilson; Terence R Flotte
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 19.456

View more
  11 in total

1.  Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.

Authors:  Mickaël Guilbaud; Marie Devaux; Celia Couzinié; Johanne Le Duff; Alice Toromanoff; Céline Vandamme; Nicolas Jaulin; Gwladys Gernoux; Thibaut Larcher; Philippe Moullier; Caroline Le Guiner; Oumeya Adjali
Journal:  Hum Gene Ther       Date:  2019-04-16       Impact factor: 5.695

2.  Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.

Authors:  Megan L Cramer; Rui Xu; Paul T Martin
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

3.  Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.

Authors:  Young Mok Lee; Thomas J Conlon; Andrew Specht; Kirsten E Coleman; Laurie M Brown; Ana M Estrella; Monika Dambska; Kathryn R Dahlberg; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2018-05-25       Impact factor: 4.982

4.  Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term CFTR Expression in Mouse Airways.

Authors:  Huibi Cao; Rongqi Duan; Jim Hu
Journal:  Genes (Basel)       Date:  2020-05-18       Impact factor: 4.096

5.  rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates.

Authors:  Akiko Ishii; Hironori Okada; Hiromi Hayashita-Kinoh; Jin-Hong Shin; Akira Tamaoka; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

6.  Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.

Authors:  Paul T Martin; Deborah A Zygmunt; Anna Ashbrook; Sonia Hamilton; Davin Packer; Sharla M Birch; Amanda K Bettis; Cynthia J Balog-Alvarez; Lee-Jae Guo; Peter P Nghiem; Joe N Kornegay
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

Review 7.  Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies.

Authors:  Wing Sum Chu; Joanne Ng
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

8.  An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque.

Authors:  Rui Xu; Ying Jia; Deborah A Zygmunt; Megan L Cramer; Kelly E Crowe; Guohong Shao; Agatha E Maki; Haley N Guggenheim; Benjamin C Hood; Danielle A Griffin; Ellyn Peterson; Brad Bolon; John P Cheatham; Sharon L Cheatham; Kevin M Flanigan; Louise R Rodino-Klapac; Louis G Chicoine; Paul T Martin
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-14       Impact factor: 6.698

Review 9.  Immune Response Mechanisms against AAV Vectors in Animal Models.

Authors:  Ashley T Martino; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2019-12-25       Impact factor: 6.698

10.  rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL/6J Mice.

Authors:  Deborah A Zygmunt; Rui Xu; Ying Jia; Anna Ashbrook; Chelsea Menke; Guohong Shao; Jung Hae Yoon; Sonia Hamilton; Harshan Pisharath; Brad Bolon; Paul T Martin
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-21       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.